{
  "id": 9211518,
  "title": "Which Is the Bigger Story for BioNTech -- Its Colorectal Cancer Vaccine Setback or the Lung Cancer Clinical Success?",
  "url": "https://urgent.news/2026/09/22/which-is-the-bigger-story-for-biontech-its-colorectal-cancer-vaccine-9211518",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-22T21:50:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/which-bigger-story-biontech-its-colorectal-cancer-vaccine-setback-or-lung-cancer-clinical"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsBioNTech recently experienced a clinical trial failure, followed by a clinical success several weeks later.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Which Is the Bigger Story for BioNTech -- Its Colorectal Cancer Vaccine Setback or the Lung Cancer Clinical Success?",
        "url": "https://urgent.news/2026/09/22/which-is-the-bigger-story-for-biontech-its-colorectal-cancer-vaccine",
        "published": "2026-09-22T21:30:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}